At Randox, Research and Development is the key to our innovation. We re-invest significantly into our research facilities to ensure we are at the forefront of diagnostics. Our large team of highly qualified and experienced scientists are dedicated to providing solutions that make a real difference to laboratory medicine. Please see below for a selection of some of our latest innovations that are set to revolutionize the industry. You can find out more about these products at our Booth #2201.
Acusera 24-7 is a web based inter-laboratory data management programme designed to support the Acusera range of internal quality controls and improve the effectiveness of QC processes within the clinical laboratory. With 24-7 peer group data is uniquely updated every 24 hours giving users access to the most up to date information available.
The new web based version eliminates the need for local installation making it the perfect solution for affiliated laboratory groups and laboratory chains.
Automated immunoturbidimetric (IT) assay for the rapid determination of the highly sensitive & specific biomarker of myocardial ischemia, Heart-Type Fatty Acid Binding Protein (H-FABP). The fully automated assay is suitable for use on a wide range of clinical chemistry instruments, with results obtained in 14 minutes using serum or plasma.
Automated assay for the urinary assessment of Aspirin “resistance” or “non-responsiveness”. This new immunoturbidimetric assay enables the quantitative determination of the highly stable metabolite of thromboxane, 11dhTxB2, and can be used on a wide range of clinical chemistry instruments.
The latest addition to the Evidence family, the Evidence Evolution is the world’s first fully automated random access biochip testing platform. State of the art intuitive E-Touch software and advanced precision Bio-drive robotics are only a few of the features the Evidence Evolution offers. Fully automated and processing in excess of 2940 tests per hour and with a world leading test menu, this analyzer will set higher standards in diagnostic testing.
As the largest and latest addition to the RX series, the RX suzuka is a fully automated, discrete random access clinical analyzer capable of running up to 1200 tests per hour including ISEs. The RX suzuka enables real cost savings to be realized with economic reagent handling maximizing tests per kit. Flexibility is guaranteed with 10 STAT sample positions allowing emergency samples to be analyzed quickly at any time.